Search Results
271 results
Your search is now limited to «Hepatitis C» expert search. 03/20/2019 09:35
Currently, second-generation direct-acting antiviral agents have been used for chronic hepatitis C treatment.
More from
Healio News 03/19/2019 13:10
As of March 3, approximately 116,000 veterans initiated all-oral HCV medications through the VA and 96,654 veterans completed treatment with sustained virologic response.
More from Healio News:
Due to the efficacy of DAA agents in curing HCV infection, the number of patients in need of transplants as a result of HCV-related liver disease is expected to decrease, with an increase in the number of HCV-uninfected patients on the waitlist.
More from American Gastroenterological Association (AGA) - Blog: 03/18/2019 15:03
March 18, 2019, 02:00:00 PM Printable Version WASHINGTON - Today the U.S. Department of Veterans Affairs (VA) announced it is on track to eliminate the hepatitis C virus (HCV) in as few as two months, in all Veterans willing and able to be treated. As of March 3, nearly 116,000 Veterans started all-oral hepatitis C medications in VA, of which 96,654 Veterans completed treatment and have been cured. 'As the largest single provider of HCV care in the U.S., this is terrific news because it means we are within striking range of eliminating...
More from
Although 2018 saw no new drug approvals to treat hepatitis C virus (HCV) infection, many studies highlighted new findings that bolstered the clinician’s ability to overcome barriers to care in treating people with the infection.
More from Gastroenterology & Endoscopy News: 03/08/2019 12:30
Further, strategies to reduce hepatitis C virus re-infections are needed to meet the goal of eliminating hepatitis C virus in these men who are at significant risk for hepatitis C virus infection.
More from
FeedNavigator 03/07/2019 12:56
Insulin resistance (IR) and type 2 diabetes (T2D) are among the serious metabolic complications for chronic hepatitis C virus (HCV) infection.
More from FeedNavigator:
Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.
More from HCV New Drugs And Liver Health:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications